Table 2.
The range of cytopenias and outcomes in different categories of antimicrobials in patients with CLD (Total n = 196).
| Item | No antimicrobials (n = 81) |
Cephalosporin (n = 86) |
Carbapenem (n = 40) |
Beta-lactams (n = 25) |
Quinolones (n = 13) |
Antifungals (n = 19) |
|---|---|---|---|---|---|---|
| Hb (g/dL) | 10.5 (8.6–12) | 8.8 (7.2–10) | 9 (6.7–10.8) | 8.8 (7.6–9.9) | 8.6 (6.5–10) | 8 (6.7–10.8) |
| TLC (×109/L) | 5.0 (3.5–7.6) | 4.9 (3.1–8.7) | 6.6 (3.3–12) | 5.1 (2.5–11) | 8.7 (2.4–14) | 4.4 (3.1–12) |
| Plt count (×109/L) | 90 (54–165) | 84.5 (40–154) | 90 (51–150) | 65 (41–110) | 64 (23–104) | 90 (50–176) |
| MELD score | 12 (8.0–13.7) | 11.5 (5.5–19.4) | 18.5 (11–28.6) | 15.4 (7.6–21) | 15.6 (7.4–32) | 12.7 (5–31.4) |
| Outcome, alive: n (%) | 70 (86.4%) | 75 (87.2%) | 21 (52.5%) | 19 (76%) | 9 (69.2%) | 10 (53%) |